1. Home
  2. SBI vs VERU Comparison

SBI vs VERU Comparison

Compare SBI & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBI
  • VERU
  • Stock Information
  • Founded
  • SBI 1992
  • VERU 1971
  • Country
  • SBI United States
  • VERU United States
  • Employees
  • SBI N/A
  • VERU N/A
  • Industry
  • SBI Finance/Investors Services
  • VERU Biotechnology: Pharmaceutical Preparations
  • Sector
  • SBI Finance
  • VERU Health Care
  • Exchange
  • SBI Nasdaq
  • VERU Nasdaq
  • Market Cap
  • SBI 104.9M
  • VERU 85.5M
  • IPO Year
  • SBI N/A
  • VERU 1990
  • Fundamental
  • Price
  • SBI $7.62
  • VERU $0.60
  • Analyst Decision
  • SBI
  • VERU Strong Buy
  • Analyst Count
  • SBI 0
  • VERU 2
  • Target Price
  • SBI N/A
  • VERU $4.00
  • AVG Volume (30 Days)
  • SBI 39.5K
  • VERU 2.5M
  • Earning Date
  • SBI 01-01-0001
  • VERU 08-07-2025
  • Dividend Yield
  • SBI 4.52%
  • VERU N/A
  • EPS Growth
  • SBI N/A
  • VERU N/A
  • EPS
  • SBI N/A
  • VERU N/A
  • Revenue
  • SBI N/A
  • VERU $16,886,419.00
  • Revenue This Year
  • SBI N/A
  • VERU N/A
  • Revenue Next Year
  • SBI N/A
  • VERU N/A
  • P/E Ratio
  • SBI N/A
  • VERU N/A
  • Revenue Growth
  • SBI N/A
  • VERU 134.43
  • 52 Week Low
  • SBI $6.96
  • VERU $0.45
  • 52 Week High
  • SBI $8.00
  • VERU $1.42
  • Technical
  • Relative Strength Index (RSI)
  • SBI 68.96
  • VERU 50.99
  • Support Level
  • SBI $7.40
  • VERU $0.54
  • Resistance Level
  • SBI $7.52
  • VERU $0.60
  • Average True Range (ATR)
  • SBI 0.05
  • VERU 0.04
  • MACD
  • SBI 0.02
  • VERU -0.01
  • Stochastic Oscillator
  • SBI 100.00
  • VERU 31.05

About SBI Western Asset Intermediate Muni Fund Inc

Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager. The Fund also maintains a dollar-weighted average effective maturity of between three and ten years.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: